Evidence map›Paper›PMID 30924280›Full record

ReviewWiley interdisciplinary reviews. Developmental biology2019

Understanding the marvels behind liver regeneration.

Anan Abu Rmilah, Wei Zhou, Erek Nelson, Li Lin, Bruce Amiot, Scott L Nyberg

Open access · greenAbstract readReview
In one paragraph

Review in Wiley interdisciplinary reviews. Developmental biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 2 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 2 syntheses or guidelines pooled it, 138 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. CD160Cellular & molecular immunology · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Wnt/β-Catenin Signaling in Liver Pathobiology.Annual review of pathology · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Anan Abu RmilahDepartment of Surgery, Division of Transplant Surgery, Mayo Clinic, Rochester, Minnesota.
Wei ZhouDepartment of Surgery, Division of Transplant Surgery, Mayo Clinic, Rochester, Minnesota.
Erek NelsonDepartment of Surgery, Division of Transplant Surgery, Mayo Clinic, Rochester, Minnesota.
Li LinDepartment of Surgery, Division of Transplant Surgery, Mayo Clinic, Rochester, Minnesota.
Bruce AmiotDepartment of Surgery, Division of Transplant Surgery, Mayo Clinic, Rochester, Minnesota.
Scott L NybergDepartment of Surgery, Division of Transplant Surgery, Mayo Clinic, Rochester, Minnesota.
Mayo Clinic · USMayo Clinic in Arizona · US

Funding

Immunodeficient FAH-/- PigsR01DK106667 · NIDDK · MAYO CLINIC ROCHESTER · PI NYBERG, SCOTT L · 2015 to 2019
$2.1M
NIDDK NIH HHS R01 DK106667
6 · The paper itself

Abstract

Tissue regeneration is a process by which the remaining cells of an injured organ regrow to offset the missed cells. This field is relatively a new discipline that has been a focus of intense research by clinicians, surgeons, and scientists for decades. It constitutes the cornerstone of tissue engineering, creation of artificial organs, and generation and utilization of therapeutic stem cells to undergo transformation to different types of mature cells. Many medical experts, scientists, biologists, and bioengineers have dedicated their efforts to deeply comprehend the process of liver regeneration, striving for harnessing it to invent new therapies for liver failure. Liver regeneration after partial hepatectomy in rodents has been extensively studied by researchers for many years. It is divided into three important distinctive phases including (a) Initiation or priming phase which includes an overexpression of specific genes to prepare the liver cells for replication, (b) Proliferation phase in which the liver cells undergo a series of cycles of cell division and expansion and finally, (c) termination phase which acts as brake to stop the regenerative process and prevent the liver tissue overgrowth. These events are well controlled by cytokines, growth factors, and signaling pathways. In this review, we describe the function, embryology, and anatomy of human liver, discuss the molecular basis of liver regeneration, elucidate the hepatocyte and cholangiocyte lineages mediating this process, explain the role of hepatic progenitor cells and elaborate the developmental signaling pathways and regulatory molecules required to procure a complete restoration of hepatic lobule. This article is categorized under: Adult Stem Cells, Tissue Renewal, and Regeneration > Regeneration Signaling Pathways > Global Signaling Mechanisms Gene Expression and Transcriptional Hierarchies > Cellular Differentiation.

Indexed as

Cell DifferentiationGene Expression RegulationLiver RegenerationAnimalsCell ProliferationHumansLiverSignal TransductionStem CellsTissue Engineeringhepatic progenitor cellliver regenerationpartial hepatectomy

Identifiers

PMID30924280
PMCPMC6457252
OpenAlexW2932211257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.